Araceli Biosciences
Araceli Biosciences Inc.
Araceli Biosciences is on a mission to transform therapeutic discovery through technologies built for speed, precision, and impact.
aracelibio.com · Tigard, OR
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$2.5M of $4.5M
Filed2026-11-03
Days since filing10
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-10-20
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Matt BeaudetExecutive Officer · Director
- Shawn MacDonaldExecutive Officer
- William CortelyouDirector
- J. William FreytagDirector
- Kirk MalloyDirector
- Sean O'NeillDirector
- Samraat RahaDirector
- Bruce RhineDirector
- Christine Ann TsingosDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$2.5M of $4.5M sold0.8 months since first sale
Prior raiseNot flaggedRaised $2.5M against a prior $2.5M$2.5M prior raise, filed 2025-01-15
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-11-044
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Field Service Engineer - US West (FSE)NOV 4Tigard, OR · open 9 days
- Field Service Engineer - US East (FSE)NOV 4Boston, MA · open 9 days
- Field Service Engineer (FSE) - UK - EuropeNOV 4Germany, London, London, City of, United Kingdom · open 9 days
- Business Development Manager - UK, EuropeNOV 4REMOTE · open 9 days
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.